Levallorphan tartrate

This classification denotes an opiate antagonist with the molecular formula C19H25NO.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U0VSF7HTN0, chemically known as 2h-10,4a-iminoethanophenanthren-6-ol, 11-allyl-1,3,4,9,10,10a-hexahydro-, tartrate but more generally known as levallorphan tartrate, which bears US NIH Compound Identifier 5464111. European Medicines Agency schedules Levallorphan tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02901MIG. Most nations, for tariff and trade purposes, schedule levallorphan tartrate under HS 29334990 and SITC 51575. As of Q4 2014, LEVALLORPHAN TARTRATE remains US FDA's Preferred Term for this commodity. Levallorphan tartrate bears US NLM identifiers UMLS ID C0770439 and NCI Concept Code C66005. SMILES: C=CCN1CC[C@]23CCCC[C@H]2[C@H]1CC4C3CC(CC4)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.